Miaomiao Bi

459 citations
20 papers · 296 indexed · h-index 13
Topics
Cancer-related molecular mechanisms research (7 papers)Corneal Surgery and Treatments (4 papers)MicroRNA in disease regulation (4 papers)
Journals
SHILAP Revista de lepidopterologíaScientific ReportsFrontiers in Immunology
Partner nations
China

In The Last Decade

Miaomiao Bi

18 papers receiving 291 citations

Peers

Miaomiao Bi
Comparison fields: 5 of 56
  • Molecular Biology 211
  • Cancer Research 140
  • Oncology 53
  • Immunology 24
  • Pulmonary and Respiratory Medicine 20
Replace Yane Gao with:
Yane Gao China
Lucia Torres Fernández Germany
Qiusheng Lan China
Kıvanç Görgülü Germany
Yasu Jiang China
Xiaowei Qi China
Zijie Mei China
Jung-Joo Choi South Korea
Miaomiao Bi relative to Yane Gao China Yane Gao's profile →
Citations per field
00.5×1.7×
Yane Gao · 1×
Citations per year

Countries citing papers authored by Miaomiao Bi

Since Specialization
Citations

This map shows the geographic impact of Miaomiao Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaomiao Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaomiao Bi more than expected).

Fields of papers citing papers by Miaomiao Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miaomiao Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaomiao Bi. The network helps show where Miaomiao Bi may publish in the future.

Co-authorship network of co-authors of Miaomiao Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Miaomiao Bi. A scholar is included among the top collaborators of Miaomiao Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miaomiao Bi. Miaomiao Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 1
4 12
5 22
6 14
7 25
8 30
9 19
10 22
11 25
12 19
13 1
14 17
15 14
16
Chloride channel protein 2 prevents glutamate-induced apoptosis in retinal ganglion cells.
0
17 1
18 12
19 52
20 5

About Miaomiao Bi

Miaomiao Bi is a scholar working on Cancer Research, Ophthalmology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 296 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Corneal Surgery and Treatments (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (140 citations), Molecular Biology (211 citations) and Sensory Systems (10 citations). Miaomiao Bi has collaborated with scholars based in China. Frequent co-authors include Sen Hong, Yumei Song, Chunyan Zhao, Lei Wang, Shiquan Li, Ling Wang, Di Sun, Qiyu Zhang, Hongyan Zhou and Lei Ding. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026